J&J Strikes Covid-19 Vaccine Manufacturing Deal With Aspen
BDX Inks Deal With Dutch Gov. For 9M Covid-19 Antigen Tests
Britain starts accelerated review for AstraZeneca’s potential Covid-19 vaccine
Black Americans Hesitant On Vaccine
Anti-Lockdown Epidemiologist Intimidated, Shamed By Contagion Of Hatred And Hysteria
November Monthly
McConnell targets 2021 for stimulus checks, but Pelosi, Trump want it sooner
Humanigen Treats First Patient in Late-Stage COVID-19 Trial
AstraZeneca Sells Rights To Hypertension Drugs For $400M
Is China An Existential Threat To America?
Martenson: We Are Pawns In A Bigger Game Than We Realize
BoJo Weighs 1-Month COVID-19 Lockdown, US Breaks Global Record For Daily Cases: Live Updates
J&J plans to test its Covid-19 vaccine in ages 12-18
All Eyes on Moderna's COVID-19 Vaccine Ahead of Data Readout
3 Biotech Stocks in the Hunt for COVID-19 Vaccine; One Analyst Calls Them a 'Buy'
Private Equity Titan Henry Kravis Says In 50 Years He Has Never Seen Markets This Volatile
US COVID-19 Cases Top 9 Million, Belgium Announces 6-Week National Lockdown: Live Updates
Week Ahead – Election Time!
Coronavirus mutation may have made it more contagious
Leveraging Platforms to CreateVaccines at Pandemic Speed
Who Do You Choose, Gold? Trump or Biden?
Regeneron Halts Covid-19 Trial For High-Flow Oxygen Patients; Shares Fall
New Covid Cases And Its Impacts On The Economy
COVID Vaccine Fallout: General Air Cargo, Wait Your Turn
AstraZeneca sells commercial rights to two drugs in $400 million deal
Indian pharma is being squeezed – and it's bad news for drug access in developing countries
AstraZeneca sells off heart failure and hypertension drugs to Cheplapharm for $400M
US Election 2020: Trump OK, Biden OK, But Neither Not OK
US Open – It’s not all doom and gloom
Covid-19 roundup: Flush with $486M contract, AstraZeneca signs Lonza up to manufacture antibodies; BioNTech's Ugur Sahin expects vaccine data 'in a fortnight'